Ross Upton is the founder and CEO of Ultromics, a University of Oxford spin-out technology company that has built an AI-based platform to predict patient outcomes in the field of cardiovascular imaging.
The “EchoGo” platform is designed to improve both clinical outcomes in patients and save billions for healthcare systems worldwide. Ross has a broad scientific background having undertaken 4 degrees in the clinical sciences. During the last 3 years, he has built Ultromics to be one of the most prominent companies in healthcare AI, leading the creation of EchoGo which has received FDA clearance and qualified for reimbursement. Ross has successfully raised multiple rounds of funding and was named on the 2019 Forbes 30 under 30 lists for science and healthcare.